Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses.

Spence JD, Stampfer MJ.

JAMA. 2011 Dec 21;306(23):2610-1. doi: 10.1001/jama.2011.1834. No abstract available.

PMID:
22187282
2.
3.

Homocysteine, B vitamins, and cardiovascular disease.

Refsum H, Smith AD.

N Engl J Med. 2006 Jul 13;355(2):207; author reply 209-11. No abstract available.

PMID:
16848014
4.

Homocysteine, B vitamins, and cardiovascular disease.

Wang X, Demirtas H, Xu X.

N Engl J Med. 2006 Jul 13;355(2):207-9; author reply 209-11. No abstract available.

PMID:
16838445
5.

Homocysteine, B-vitamins, and the risk of cardiovascular disease.

Clarke R, Smulders Y, Fowler B, Stehouwer CD.

Semin Vasc Med. 2005 May;5(2):75-6. Review. No abstract available.

PMID:
16047260
6.

Homocysteine lowering and cardiovascular disease risk: lost in translation.

Marcus J, Sarnak MJ, Menon V.

Can J Cardiol. 2007 Jul;23(9):707-10. Review.

7.

Interventions for lowering plasma homocysteine levels in dialysis patients.

Nigwekar SU, Kang A, Zoungas S, Cass A, Gallagher MP, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli GF, Jardine MJ.

Cochrane Database Syst Rev. 2016 May 31;(5):CD004683. doi: 10.1002/14651858.CD004683.pub4. Review.

PMID:
27243372
8.

Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?

Debreceni B, Debreceni L.

Cardiovasc Ther. 2012 Aug;30(4):227-33. doi: 10.1111/j.1755-5922.2011.00266.x. Epub 2011 Apr 1. Review.

PMID:
21884001
9.

Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?

Lonn E.

JAMA. 2008 May 7;299(17):2086-7. doi: 10.1001/jama.299.17.2086. No abstract available.

PMID:
18460669
10.

C(1) metabolism and CVD outcomes in older adults.

McNulty H, Strain JJ, Pentieva K, Ward M.

Proc Nutr Soc. 2012 May;71(2):213-21. doi: 10.1017/S0029665111003387. Epub 2011 Dec 12. Review.

PMID:
22152927
11.

Homocysteine-lowering trials for prevention of heart disease and stroke.

Clarke R.

Semin Vasc Med. 2005 May;5(2):215-22. Review.

PMID:
16047274
12.

Homocysteine, B-vitamins and CVD.

McNulty H, Pentieva K, Hoey L, Ward M.

Proc Nutr Soc. 2008 May;67(2):232-7. doi: 10.1017/S0029665108007076. Review.

PMID:
18412997
13.

[Nutritional medicine 2007].

Hauner H.

Dtsch Med Wochenschr. 2007 Jun 22;132(25-26):1411-3. Review. German. No abstract available.

PMID:
17570092
14.

[Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHRF) genotype].

González Ordóñez AJ, Medina Rodríguez JM, Fernández Alvarez CR, Sánchez García J, Fernández Carreira JM, Alvarez Martínez MV, Coto García E.

Med Clin (Barc). 2000 Jan 15;114(1):7-12. Spanish.

PMID:
10782453
15.

Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.

Ebbing M, Bønaa KH, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, Njølstad I, Nilsen DW, Refsum H, Tverdal A, Vollset SE, Schirmer H, Bleie Ø, Steigen T, Midttun Ø, Fredriksen A, Pedersen ER, Nygård O.

J Intern Med. 2010 Oct;268(4):367-82. doi: 10.1111/j.1365-2796.2010.02259.x.

16.

The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.

Debreceni B, Debreceni L.

Cardiovasc Ther. 2014 Jun;32(3):130-8. doi: 10.1111/1755-5922.12064. Review.

PMID:
24571382
17.

The controversial role of B-vitamins in cardiovascular risk: An update.

Ntaios G, Savopoulos C, Grekas D, Hatzitolios A.

Arch Cardiovasc Dis. 2009 Dec;102(12):847-54. doi: 10.1016/j.acvd.2009.07.002. Review.

18.

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

B-Vitamin Treatment Trialists' Collaboration.

Am Heart J. 2006 Feb;151(2):282-7. Review.

PMID:
16442889
19.

Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.

Lonn E, Held C, Arnold JM, Probstfield J, McQueen M, Micks M, Pogue J, Sheridan P, Bosch J, Genest J, Yusuf S; HOPE-2 Investigators.

Can J Cardiol. 2006 Jan;22(1):47-53.

20.

Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.

Zee RY, Mora S, Cheng S, Erlich HA, Lindpaintner K, Rifai N, Buring JE, Ridker PM.

Clin Chem. 2007 May;53(5):845-51. Epub 2007 Mar 1.

Supplemental Content

Support Center